Subject(s)
Federal Government , Science , Politics , Science/legislation & jurisprudence , United KingdomSubject(s)
Goals , Leadership , Public Policy/legislation & jurisprudence , Science/legislation & jurisprudence , Science/organization & administration , Technology/legislation & jurisprudence , Technology/organization & administration , China , Climate Change , Competitive Behavior , Cooperative Behavior , European Union , Humans , Pandemics , Politics , Public Policy/economics , Public Policy/trends , Public-Private Sector Partnerships , Science/economics , Science/trends , Social Sciences , Technology/economics , Technology/trends , United StatesSubject(s)
Federal Government , Leadership , Policy Making , Politics , Science , Budgets/legislation & jurisprudence , COVID-19/economics , COVID-19/epidemiology , COVID-19/mortality , COVID-19/prevention & control , Climate Change , Communicable Disease Control , Germany/epidemiology , Gross Domestic Product , Humans , Internationality , Science/economics , Science/legislation & jurisprudenceSubject(s)
Federal Government , Politics , Research Personnel , Science/legislation & jurisprudence , Advisory Committees , Centers for Disease Control and Prevention, U.S./legislation & jurisprudence , Centers for Disease Control and Prevention, U.S./standards , Climate Change , Science/standards , United States , United States Environmental Protection Agency/legislation & jurisprudence , United States Environmental Protection Agency/standardsSubject(s)
Cooperative Behavior , Environmental Policy/legislation & jurisprudence , Federal Government , Health Policy/legislation & jurisprudence , Policy Making , Science/legislation & jurisprudence , Science/organization & administration , Communication , Environmental Policy/economics , Goals , Politics , Public Opinion , Race Relations/legislation & jurisprudence , Science/economics , United StatesSubject(s)
Budgets/legislation & jurisprudence , Federal Government , Research Personnel , Science/economics , Science/legislation & jurisprudence , Security Measures/economics , Security Measures/legislation & jurisprudence , China , Competitive Behavior , International Cooperation/legislation & jurisprudence , Inventions/economics , Inventions/legislation & jurisprudence , Military Science , Politics , United States , Universities/economicsSubject(s)
COVID-19 , Politics , Science/legislation & jurisprudence , Science/organization & administration , Security Measures , COVID-19/epidemiology , CRISPR-Cas Systems , China , Disaster Planning/organization & administration , Humans , International Cooperation , Pandemics/prevention & control , Pandemics/statistics & numerical data , Policy Making , Prejudice/prevention & control , Research Support as Topic/organization & administration , Science/ethics , Science/standards , United States/epidemiologySubject(s)
Federal Government , Leadership , Policy Making , Science/legislation & jurisprudence , Sociology , Advisory Committees/organization & administration , Bioethics , COVID-19/epidemiology , COVID-19/prevention & control , Global Warming/legislation & jurisprudence , Global Warming/prevention & control , Humans , Racism/prevention & control , United StatesSubject(s)
Advisory Committees/organization & administration , Advisory Committees/standards , COVID-19 , Federal Government , Policy Making , Science , Universities/economics , Advisory Committees/ethics , COVID-19/epidemiology , COVID-19/prevention & control , Humans , Science/economics , Science/legislation & jurisprudence , Science/organization & administration , United StatesSubject(s)
COVID-19/epidemiology , Environmental Policy/legislation & jurisprudence , Federal Government , Politics , Public Health/legislation & jurisprudence , Science/legislation & jurisprudence , Centers for Disease Control and Prevention, U.S./ethics , Centers for Disease Control and Prevention, U.S./legislation & jurisprudence , China , Democracy , Emigration and Immigration/legislation & jurisprudence , Foreign Professional Personnel/legislation & jurisprudence , Humans , Pandemics , Research Personnel/legislation & jurisprudence , Time Factors , United States/epidemiology , United States Environmental Protection Agency/ethics , United States Environmental Protection Agency/legislation & jurisprudence , United States Food and Drug Administration/ethics , United States Food and Drug Administration/legislation & jurisprudenceSubject(s)
Environmental Policy/legislation & jurisprudence , Health Policy/legislation & jurisprudence , Science/legislation & jurisprudence , Supreme Court Decisions , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Politics , United States , Women's Rights/legislation & jurisprudenceSubject(s)
Democracy , Federal Government , Leadership , Periodicals as Topic , Science , COVID-19 , COVID-19 Vaccines , Centers for Disease Control and Prevention, U.S./organization & administration , Centers for Disease Control and Prevention, U.S./standards , Contact Tracing , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Global Warming/prevention & control , Humans , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Science/legislation & jurisprudence , Science/standards , Trust , United States/epidemiology , United States Environmental Protection Agency/organization & administration , Viral Vaccines , COVID-19 Drug TreatmentSubject(s)
Coronavirus Infections , Evidence-Based Medicine , Federal Government , International Cooperation , Pandemics , Pneumonia, Viral , Policy Making , Science/legislation & jurisprudence , Science/standards , COVID-19 , Communication , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Democracy , Environmental Policy/legislation & jurisprudence , Health Policy/legislation & jurisprudence , Hope , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Science/trends , United States , United States Environmental Protection Agency , United States Food and Drug Administration , World Health Organization/organization & administrationSubject(s)
Biomedical Research/legislation & jurisprudence , Climate Change , Federal Government , Foreign Professional Personnel/legislation & jurisprudence , Pandemics/legislation & jurisprudence , Science/legislation & jurisprudence , Science/trends , Space Flight/legislation & jurisprudence , COVID-19 , COVID-19 Vaccines , China , Contact Tracing , Coronavirus Infections/economics , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Democracy , Disaster Planning , Emigration and Immigration/legislation & jurisprudence , Humans , Intellectual Property , International Cooperation/legislation & jurisprudence , Pandemics/economics , Pandemics/prevention & control , Pneumonia, Viral/economics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Politics , United States/epidemiology , United States National Aeronautics and Space Administration/legislation & jurisprudence , Viral Vaccines/economics , Viral Vaccines/supply & distribution , World Health Organization/economics , World Health Organization/organization & administrationABSTRACT
In times of planetary health crises such as the COVID-19 pandemic, a critically informed science and technology policy is crucial. In this overarching context, governments are faced with making rapid and high-stake decisions dictated by emergency that in a state of normalcy they would not, or could not pursue. Governments tend to gather, therefore, an incredible amount of unchecked power in times of fast-moving ecological crises that raises concerns about where the legitimacy of such excessive power comes from. Moreover, the elected politicians rely on the expert advice in a pandemic. This takes away democratic political authority from the sovereign people and instead places it on allegedly objective unelected experts. In contrast, experts have (1) a dubious reputation in predicting the future and (2) varying degrees of biases and self-interests, which make them susceptible, for instance, to "framing problems" in relation to the urgent public issues at stake. This article suggests new ways of thinking about COVID-19 technology policy, drawing from the field of political science and democratic theory. It examines the power-laden tensions between the political authority and the expert authority. Going forward, I highlight the brief history of epistemic democracy, taking into consideration that in advanced modern democracies, political decision making has to draw, in part, from expert knowledge, but without resulting in democratic deficits. The COVID-19 science and technology policy can usefully build on epistemic democracy while strengthening the science, society, and democracy nexus.